President, CEO of Cadence Pharmaceuticals Inc. (CADX, Financial) Theodore R Schroeder sells 30,000 shares of CADX on 01/04/2010 at an average price of $9.77 a share.
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers. Cadence Pharmaceuticals Inc. has a market cap of $487.87 million; its shares were traded at around $9.67 .
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III products in development, including IV APAP, for the treatment of acute pain and fever, and Omigard for the prevention of catheter-related infections. The Company is committed to the fevelopment and commercialization of pharmaceuticals to meet the needs of hospitalized patients and their caregivers. Cadence Pharmaceuticals Inc. has a market cap of $487.87 million; its shares were traded at around $9.67 .
CEO Recent Trades:
- Sell:: President, CEO Theodore R Schroeder sold 20,000 shares of CADX stock on 10/16/2009 at the average price of 10.72, the price of the stock has decreased by 9.79% since.
Directors and Officers Recent Trades:
- Sell:: EVP, CMO James B Breitmeyer sold 1,000 shares of CADX stock on 12/17/2009 at the average price of 10, the price of the stock has decreased by 3.3% since.
- Sell:: SVP William S Craig sold 10,000 shares of CADX stock on 12/17/2009 at the average price of 10, the price of the stock has decreased by 3.3% since.
- Sell:: SVP David A Socks sold 2,500 shares of CADX stock on 12/17/2009 at the average price of 10, the price of the stock has decreased by 3.3% since.
- Sell:: SVP David A Socks sold 10,000 shares of CADX stock on 12/14/2009 at the average price of 9.34, the price of the stock has increased by 3.53% since.
- Sell:: SVP David A Socks sold 12,500 shares of CADX stock on 11/09/2009 at the average price of 10, the price of the stock has decreased by 3.3% since.
